CSE: TRYP
Revenue (ttm)
Gross Profit (ttm)
Diluted EPS (ttm)
Dr. James P. Gilligan MSIB, Ph.D.
Interim CEO, Pres & Chief Scientific Officer
Dr. James S. Kuo M.B.A., M.D.
Co-Founder & Director
Mr. Thomas D'Orazio B.Sc., M.B.A.
Chief Operating Officer
Mr. Sidney Taubenfeld R.Ph
Chief Operating Officer
Ms. Joy Willis
Director of Investor Relations
Market Capitalization
$5,148,835
Shares Outstanding
60,302,222
Shares Short (% of Float)
()
Insider Ownership
48%